In vitro and in vivo evaluation of the genotoxicity of N-nitrosooxprenolol.
N-nitrosooxprenolol (NO-oxprenolol) might be formed in the stomach of patients taking the beta-adrenergic blocking drug, oxprenolol. This nitroso derivative has previously been shown to induce DNA damage and repair in both rat and human cultured hepatocytes. The results of the present study show that in the presence of co-cultured rat hepatocytes, 0.03 mM NO-oxprenolol produced a significant increase in the frequency of 6-thioguanine-resistant but not of ouabain-resistant mutants. No mutagenic activity was detected in the absence of metabolic activation. In mice, NO-oxprenolol (1 g/kg) increased the incidence of micronucleated cells in the liver but not in the bone marrow and the spleen. These results suggest that NO-oxprenolol, consistent with its chemical nature of nitrosamine, is biotransformed into short-lived reactive species.
Martelli
A
A
Institute of Pharmacology, University of Genova, Italy.
Canonero
R
R
Allavena
A
A
Sottofattori
E
E
Brambilla
G
G
D000818:Animals; D001711:Biotransformation; D002478:Cells, Cultured; D006224:Cricetinae; D003412:Cricetulus; D004249:DNA Damage; D004351:Drug Resistance; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D008099:Liver / Q000166:cytology; D008168:Lung / Q000166:cytology; D008297:Male; D051379:Mice; D009152:Mutagenicity Tests; D009154:Mutation / Q000187:drug effects*; D009602:Nitrosamines / Q000493:pharmacokinetics / Q000633:toxicity*; D010096:Oxprenolol / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000633:toxicity; D051381:Rats
D009602:Nitrosamines; D010096:Oxprenolol; C077607:N-nitrosooxprenolol